Summary
An alteration of an amino acid sequence in the processing site of the insulin proreceptor by a point mutation of the insulin receptor gene produced extreme insulin resistance. We characterized functional properties of the unprocessed insulin receptor in transformed lymphocytes from a patient. Insulin binding to intact cells and to a partially purified insulin receptor preparation was radically decreased to 20% and 18% of the control values, respectively. In competitive insulin binding to intact cells, [LeuA3]-, [LeuB24]-, [SerB24-insulin, and mini-proinsulin ([B(1–29)-Ala-Ala-Lys-A(1–21)]-insulin) had the same relative binding activity in both the patient's and the control cells, but proinsulin and IGF-I were markedly less able to displace 125I-insulin in the patient's cells. In contrast to the study in intact cells, proinsulin and IGF-I as well as other insulin analogues had the same relative binding activity to bind to the partially lectin-purified insulin receptor preparations from both the patient's and the control cells. As regards the signal transduction after receptor binding, insulin-stimulated autophosphorylation of the unprocessed insulin proreceptor occurred proportionally to the amount of decreased insulin binding. With 0.025% trypsin treatment, the abnormal binding characteristics and autophosphorylation were normalized through conversion to functionally normal receptors. In spite of the abnormal processing, self-association of receptors into oligomeric structures was observed in the proreceptor. These results suggest that the unprocessed insulin proreceptor in the plasma membranes has an altered conformation which affects its binding characteristics but not its intramolecular signal transmission.
Article PDF
Similar content being viewed by others
References
Kahn CR (1976) Membrane receptors for hormones and neurotransmitters. J Cell Biol 70: 261–286
Freychet P, Kahn CR, Roth J, Neville DM (1972) Insulin interactions with liver plasma membranes: independence of binding of the hormone and its degradation. J Biol Chem 247: 3953–3961
Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J (1976) The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 294: 739–745
Taylor SI, Samuels B, Roth J, Kasuga M, Hedo JA, Gorden P, Brasel DE, Pokora T, Engel RR (1982) Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance. J Clin Endocrinol Metab 54: 919–930
Scarlett JA, Kolterman OG, Moore P, Saekow M, Insel J, Griffin J, Mako M, Rubenstein AH, Olefsky JM (1982) Insulin resistance and diabetes due to a genetic defect in insulin receptors. J Clin Endocrinol Metab 55: 123–132
Podskalny JM, Kahn CR (1982) Cell culture studies on patients with extreme insulin resistance. I. Receptor defects on cultured fibroblasts. J Clin Endocrinol Metab 54: 261–268
Podskalny JM, Kahn CR (1982) Cell culture studies on patients with extreme insulin resistance. II. Abnormal biological responses in cultured fibroblasts. J Clin Endocrinol Metab 54: 269–275
Grunberger G, Zick Y, Gorden P (1984) Defect in phosphorylation of insulin receptors in cells from an insulin-resistant patient with normal insulin binding. Science 223: 932–934
Grigorescu F, Flier JS, Kahn CR (1984) Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance. J Biol Chem 259: 15003–15006
Grunberger G, Comi RJ, Taylor SI, Gorden P (1984) Tyrosine kinase activity of the insulin receptor of patients with type A extreme insulin resistance: studies with circulating mononuclear cells and cultured lymphocytes. J Clin Endocrinol Metab 59: 1152–1158
Whittaker J, Zick Y, Roth J, Taylor SI (1985) Insulin-stimulated receptor phosphorylation appears normal in cultured Epstein-Barr virus-transformed lymphocyte cell lines derived from patients with extreme insulin resistance. J Clin Endocrinol Metab 60: 381–386
Grigorescu F, Flier JS, Kahn CR (1986) Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance. Diabetes 35: 127–138
Hedo JA, Moncada VY, Taylor SI (1985) Insulin receptor biosynthesis in cultured lymphocytes from insulin-resistant patients. J Clin Invest 76: 2355–2361
McElduff A, Hedo JA, Taylor SI, Roth J, Gorden P (1984) Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance. J Clin Invest 74: 1366–1374
Kobayashi M, Olefsky IM, Elders J, Mako ME, Given BD, Schedwie HK, Fiser RH, Hintz RL, Horner JA, Rubenstein AH (1978) Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism. Proc Natl Acad Sci USA 75: 3469–3473
Taylor SI, Roth J, Blizzard RM, Elders MJ (1981) Qualitative abnormalities in insulin binding in a patient with extreme insulin resistance: decreased sensitivity to alterations in temperature and pH. Proc Natl Acad Sci USA 78: 7157–7161
Taylor SI, Hedo JA, Underhill LH, Kasuga M, Elders MJ, Roth J (1982) Extreme insulin resistance in association with abnormally high binding affinity of insulin receptors from a patient with leprechaunism: evidence for a defect intrinsic to the receptor. J Clin Endocrinol Metab 55: 1108–1113
Craig JW, Larner J, Locker EF, Widom B, Elders MJ (1984) Mechanisms of insulin resistance in cultured fibroblasts from a patient with leprechaunism: impaired post-binding actions of insulin and multiplication-stimulating activity. Metabolism 33: 1084–1096
Schilling EE, Rechler MM, Grunfeld C, Rosenberg AM (1979) Primary defect of insulin receptors in skin fibroblasts cultured from an infant with leprechaunism and insulin resistance. Proc Natl Acad Sci USA 76: 5877–5881
Knight AB, Rechler MM, Romanus JA, Van Obberghen-Schilling EE, Nissley SP (1981) Stimulation of glucose incorporation and amino acid transport by insulin and an insulin-like growth factor in fibroblasts with defective insulin receptors cultured from a patient with leprechaunism. Proc Natl Acad Sci USA 78: 2554–2558
D'Ercole AJ, Underwood EE, Groelke J, Plet A (1979) Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation. J Clin Endocrinol Metab 48: 495–502
Kaplowitz PB, D'Ercole AJ (1982) Fibroblasts from a patient with leprechaunism are resistant to insulin, epidermal growth factor, and somatomedin C. J Clin Endocrinol Metab 55: 741–748
Cama A, Taylor SI (1987) Tyrosine kinase activity of insulin receptors from an insulin-resistant patient with leprechaunism. Diabetologia 30: 631–637
Kobayashi M, Takata Y, Sasaoka T, Shigeta Y, Goji K (1988) Fluctuation of insulin resistance in a leprechaun with a primary defect in insulin binding. J Clin Endocrinol Metab 66: 1084–1088
Taylor SI, Underhill LH, Hedo JA, Roth J, Rios MS, Blizzard RM (1983) Decreased insulin binding to cultured cells from a patient with the Rabson-Mendenhall syndrome: dichotomy between studies with cultured lymphocytes and cultured fibroblasts. J Clin Endocrinol Metab 56: 856–861
Moncada VY, Hedo JA, Serrano-Rios M, Taylor SI (1986) Insulin-receptor biosynthesis in cultured lymphocytes from an insulin-resistant patient (Rabson-Mendenhall syndrome): evidence for defect before insertion of receptor into plasma membrane. Diabetes 35: 802–807
Takata Y, Kobayashi M, Maegawa H, Watanabe N, Ishibashi O, Shigeta Y, Fujinami A (1986) A primary defect in insulin receptor in a young male patient with insulin resistance. Metabolism 35: 950–955
Kobayashi M, Sasaoka T, Takata Y, Hisatomi A, Shigeta Y (1988) Insulin resistance by uncleaved insulin pro-receptor: emergence of binding site by trypsin. Diabetes 37: 653–656
Sasaoka T, Shigeta Y, Takata Y, Ishibashi O, Sugibayashi M, Hisatomi A, Kobayashi M (1989) Unprocessed insulin proreceptor in cultured fibroblasts from a patient with extreme insulin resistance. Metabolism (in press)
Kakehi T, Hisatomi A, Kuzuya H, Yoshimasa Y, Okamoto M, Yamada K, Nishimura H, Kosaki A, Nawata H, Umeda F, Ibayashi H, Imura H (1988) Defective processing of insulin-receptor precursor in cultured lymphocytes from a patient with extreme insulin resistance. J Clin Invest 81: 2020–2022
Kobayashi M, Sasaoka T, Takata Y, Ishibashi O, Sugibayashi M, Shigeta Y, Hisatomi A, Nakamura E, Tamaki M, Teraoka H (1988) Insulin resistance by unprocessed insulin proreceptors: point mutation at the cleavage site. Biochem Biophys Res Comm 153: 657–663
Yoshimasa Y, Seino S, Whittaker J, Kakehi T, Kosaki A, Kuzuya H, Imura H, Bell GI, Steiner DF (1988) Insulin-resistant diabetes due to a point mutation that prevents insulin proreceptor processing. Science 240: 784–787
Kobayashi M, Takata Y, Ishibashi O, Sasaoka T, Iwasaki M, Shigeta Y, Inouye K (1986) Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin. Biochem Biophys Res Comm 137: 250–257
Kobayashi M, Ohgaku S, Iwasaki M, Maegawa H, Shigeta Y, Inouye K (1982) Characterization of [LeuB-24]- and [LeuB-25]-insulin analogues: receptor binding and biological activity. Biochem J 206: 597–603
Kobayashi M, Haneda M, Maegawa H, Watanabe N, Takata Y, Shigeta Y, Inouye K (1984) Receptor binding and biological activity of [SerB-24]-insulin, an abnormal mutant insulin. Biochem Biophys Res Commun 119: 49–57
Kobayashi M, Sasaoka T, Sugibayashi M, Iwanishi M, Shigeta Y (1989) Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology. Diabetes Res Clin Pract (in press)
Taylor SI, Schroer JA, Marcus-Samuels B, McElduff A, Bender TP (1984) Binding of insulin to its receptor impairs recognition by monoclonal anti-insulin antibodies. Diabetes 33: 778–784
Hedo JA, Kahn CR, Hayashi M, Yamada KM, Kasuga M (1983) Biosynthesis and glycosylation of the insulin receptor: evidence for a single polypeptide precursor of the two major subunits. J Biol Chem 258: 10020–10026
Riedel H, Dull TJ, Schlessinger J, Ullrich A (1986) A chimeric receptor allows insulin to stimulate tyrosine kinase activity of epidermal growth factor receptor. Nature 324: 68–70
Hatakeyama M, Doi T, Kono T, Maruyama M, Minamoto S, Mori H, Kobayashi M, Uchiyama T, Taniguchi T (1987) Transmembrane signaling of interleuken 2 receptor: conformation and function of human interleukin 2 receptor (p55)/insulin receptor chimeric molecules. J Exp Med 166: 362–375
Olson TS, Bamberger MJ, Lane MD (1988) Post-translational changes in tertiary and quaternary structure of the insulin proreceptor: correlation with acquisition of function. J Biol Chem 263: 7342–7351
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sasaoka, T., Shigeta, Y., Takata, Y. et al. Binding specificity and intramolecular signal transmission of uncleaved insulin proreceptor in transformed lymphocytes from a patient with extreme insulin resistance. Diabetologia 32, 371–377 (1989). https://doi.org/10.1007/BF00277261
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00277261